Drug profile · INN
naftifine hydrochloride
NAFTIFINE HYDROCHLORIDE
naftifine hydrochloride (NAFTIFINE HYDROCHLORIDE) is a squalene monooxygenase inhibitor. Associated with Amneal Pharma Europe Ltd. Route of administration: topical. Current US regulatory status: approved.
Drug details — naftifine hydrochloride
- US status
- approved
- Class
- —
- Route
- TOPICAL
- Patents
- 0
- Programs
- 0
- Data quality
- 0.89
Quick answer
naftifine hydrochloride (NAFTIFINE HYDROCHLORIDE) is a squalene monooxygenase inhibitor. Associated with Amneal Pharma Europe Ltd. Route of administration: topical. Current US regulatory status: approved.
Key facts
Mechanism of action
Squalene monooxygenase inhibitor
Primary target: Squalene monooxygenase
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is naftifine hydrochloride?
naftifine hydrochloride (NAFTIFINE HYDROCHLORIDE) is a squalene monooxygenase inhibitor. Associated with Amneal Pharma Europe Ltd. Route of administration: topical. Current US regulatory status: approved.
What is the brand name for naftifine hydrochloride?
NAFTIFINE HYDROCHLORIDE is a marketed brand name for naftifine hydrochloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of naftifine hydrochloride?
naftifine hydrochloride has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.